Lazard Asset Management’s Stoke Therapeutics STOK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $156K | Buy |
+13,832
| New | +$156K | ﹤0.01% | 1759 |
|
|
2025
Q1 | – | Sell |
-58
| Closed | – | – | 2573 |
|
|
2024
Q4 | $0 | Hold |
58
| – | – | ﹤0.01% | 2529 |
|
|
2024
Q3 | $0 | Sell |
58
-155
| -73% | – | ﹤0.01% | 2450 |
|
|
2024
Q2 | $2K | Sell |
213
-3,497
| -94% | -$32.8K | ﹤0.01% | 2112 |
|
|
2024
Q1 | $49K | Sell |
3,710
-2,069
| -36% | -$27.3K | ﹤0.01% | 1718 |
|
|
2023
Q4 | $29K | Buy |
5,779
+222
| +4% | +$1.11K | ﹤0.01% | 2018 |
|
|
2023
Q3 | $21K | Buy |
5,557
+2,723
| +96% | +$10.3K | ﹤0.01% | 2090 |
|
|
2023
Q2 | $29K | Buy |
2,834
+930
| +49% | +$9.52K | ﹤0.01% | 2015 |
|
|
2023
Q1 | $15K | Buy |
1,904
+407
| +27% | +$3.21K | ﹤0.01% | 2097 |
|
|
2022
Q4 | $13K | Buy |
+1,497
| New | +$13K | ﹤0.01% | 2180 |
|